@narrowit.bsky.socialAbbVie Highlights Long-Term IBD Results for Skyrizi and Rinvoq
AbbVie reported long-term and real-world inflammatory-bowel-disease findings across 20 presentations at UEG Week 2026.
https://www.narrowit.com/news/abbvie-skyrizi-rinvoq-long-term-ibd-data-2026-10-17
@newsen.bsky.socialNew Insights on SKYRIZI® and RINVOQ® Showcase Long-Term Efficacy in IBD Management at UEG Week 2026 #USA #AbbVie #North_Chicago #Skyrizi #RINVOQ
@newsen.bsky.socialAbbVie Unveils Positive Phase 3 AFFIRM Study Results for SKYRIZI Treatment in Crohn's Disease #USA #Crohn's_Disease #AbbVie #North_Chicago #Skyrizi
@newsen.bsky.socialNew AbbVie Data Shows Effective Management of Inflammatory Bowel Disease with SKYRIZI and RINVOQ #United_States #Nashville #Inflammatory_Bowel_Disease #Skyrizi #RINVOQ
@orthocsi2025.bsky.social@newsen.bsky.socialAbbVie Receives New Approval for Pediatric Use of Skyrizi in Psoriasis Treatment #Japan #Tokyo #Psoriasis #AbbVie #Skyrizi
@neurodivergentbc.bsky.social#Skyrizi always makes me feel weird for a day or two after taking it. Good thing it’s something I only have to take every 8 weeks. #Crohn’s #Crohn’sDisease #IBD #InflamatoryBowelDisease
@adarkhairedone.bsky.socialEarlier today I injected with the on-body injector my dose of #Skyrizi. This'll repeat on Th 29 OC 2026. #PhysicalHealing #CrohnsDisease #IBD